Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead

SIMPLE SUMMARY: We have previously shown that overexpression of BST-2 in breast cancer cells promotes cancer cell adhesion and aggressiveness. Although the level of BST-2 in breast tumors is higher than those of established cancer markers, there is no therapy targeting BST-2 in cancer cells. Thus, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Yuan, Kopcho, Steven, Alvarez, Folnetti A., Okeoma, Bryson C., Okeoma, Chioma M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563317/
https://www.ncbi.nlm.nih.gov/pubmed/32872253
http://dx.doi.org/10.3390/cancers12092448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563317/
https://www.ncbi.nlm.nih.gov/pubmed/32872253
http://dx.doi.org/10.3390/cancers12092448

Ejemplares similares